Abstracts

LESSONS LEARNED AND CHALLENGES IN COVID-19 VACCINE TRIALS

In 2020, the development of SARS-CoV-2 vaccines proceeded at a historic pace. Facing many challenges early on – a new disease poorly understood immunity, and an uncertain trajectory of the outbreak – a U.S. government effort brought together many partners to develop and advance several SARS-CoV2 vaccines. The vaccine development model included harmonized trial designs,…

EQUITABLE ROLL-OUT OF COVID-19 VACCINES IN THE UNITED STATES

The United States is experiencing an intense reckoning with structural racism, in part because of the disparate health effects of COVID-19 on racial minorities suffering from higher rates of infection, hospitalization, and death. Yet despite equity efforts, we are already seeing racial disparities in vaccine distribution across the country. Going forward, vaccination efforts should prioritize…

VACCINE ACCEPTANCE

Vaccine acceptance is a complex phenomenon that lies on a continuum with those who actively seek vaccination on one end and those who refuse all vaccines on the other. When we talk about vaccine hesitancy, we mean those who accept some, delay some, or refuse some vaccines. Where one lies on this continuum is the…

NOVEL FINDINGS OF NEURONAL MODULATION OF HIV EXPRESSION IN MICROGLIA

Although cART dramatically lowers the levels of viral RNA in the brain, it does not reduce the incidence of HIV-associated neurocognitive disorders (HAND), which still develop in up to 50% of HIV patients. Initial studies indicated paradoxically that the development of HAND correlates strongly with systemic inflammation and CNS inflammation, but did not correlate with…

ROLE OF CNS CD4 T CELLS AND MACROPHAGES IN SIV NEUROPATHOGENESIS AND RESERVOIRS

While the use of combination antiretroviral therapy effectively suppresses systemic viral replication, neurocognitive disorders remain a persistent clinical problem. Therefore, the use non-human primate models are necessary to study mechanisms of neuropathogenesis. Simian immunodeficiency virus (SIV)–infected non-human primates can serve as a relevant model for AIDS neuropathogenesis. The current SIV-induced encephalitis (SIVE)/neuroAIDS models are generally…